Blue Companion
BLUE COMPANION provides digital services for health through private-public partnership projects. They also offer CRO services by designing and conducting clinical studies, as well as providing project management and study management services. Their privileged therapeutic domains are neurodegenerative and neuromuscular diseases, as well as ophthalmology.
BLUECompanion also designs, deploys and manages customised integrated ICT platforms to treat and monitor on quasi real time different data sources (auto-evaluation questionnaires, wearable devices, robotic interfaces, mobile phones…).
Learn more: www.bluecompanion.eu
A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT
64 +
countries
involved
20 000 +
investigational
Centres
3 million +
patients
in database
50 000 +
users
worlwide
LATEST NEWSOUR NEWS >
March 26, 2025
April 4, 2025 – Maison de la Chimie, Paris You are invited to the first edition of an annual event dedicated to preventive and longevity medicine—an unprecedented gathering of experts, decision-makers, and key players in the healthcare ecosystem. Held in a prestigious institutional venue, this event will explore the latest clinical results, ad hoc technological […]
March 26, 2025
April 29, 2025 – 1:15 PM – 2:00 PM CEST (Webinar) Join our upcoming webinar in collaboration with PharmaLex to explore current challenges in clinical trials for targeted therapies. We’ll discuss how eClinical solutions can optimize processes from managing complex data to coordinating stakeholders and enabling real-time decision-making. This interactive session is designed for industry […]
March 26, 2025
MedCity News Considering the lack of high quality data, companies that excel in compiling and managing data effectively are attracting interest from industry partners and distinguishing themselves from their rivals. Here are some of the ways emerging AI applications are fueling and redefining the need for RWD across HCLS. The last half decade has brought […]